From nanoscale to global scale: Advancing MIT’s special initiatives in manufacturing, health, and climate
MIT.nano cleanroom complex named after Robert Noyce PhD ’53 at the 2025 Nano Summit.
MIT.nano cleanroom complex named after Robert Noyce PhD ’53 at the 2025 Nano Summit.
Founded by a team from MIT, Lamarr.AI uses drones, thermal imaging, and AI to help property owners make targeted investments in their buildings.
Co-founded by Kanav Setia and Jason Necaise ’20, qBraid lets users access the most popular quantum devices and software programs on an intuitive, cloud-based platform.
Founded by Sam Calisch SM ’14, PhD ’19, Copper offers electric kitchen ranges that plug into standard wall outlets, with no electrical upgrades required.
An MIT team’s technology could allow cancer drugs to be delivered more steadily into the bloodstream, to improve effectiveness and reduce side effects.
Twelve START.nano companies competed for the grand prize of nanoBucks to be used at MIT.nano’s facilities.
Co-founded by an MIT alumnus, Watershed Bio offers researchers who aren’t software engineers a way to run large-scale analyses to accelerate biology.
Bakshi will help shape and scale entrepreneurship education and platform at MIT.
This year’s delta v summer accelerator offered an up-close look at how AI is changing the process of building a startup.
Cache DNA has developed technologies that can preserve biomolecules at room temperature to make storing and transporting samples less expensive and more reliable.
A system conceived in Professor Michael Cima’s lab was approved by the Food and Drug Administration after positive results in patients.
MIT student teams celebrate business milestones at the capstone event for the 2025 delta v summer accelerator.
Ianacare, co-founded by Steven Lee ’97, MEng ’98, equips caregivers with the resources, networks, and tools they need to support loved ones.
Storage systems from Cloudian, co-founded by an MIT alumnus, are helping businesses feed data-hungry AI models and agents at scale.
MIT spinout Tissium recently secured FDA marketing authorization of a biopolymer platform for nerve repair.